Agios Pharmaceuticals Inc (AGIO)
R&D Expense Growth
26.28%
Quarterly · Period ending:
AGIO R&D Expense Growth
Latest reported26.28%period ending
Latest reported26.28%period ending
AGIO Quarterly R&D Growth (QoQ) (0.00% → 26.28%)
Latest values, visible window
High-resolution chart · PNG
AGIO r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 26.2819% | |
| -8.0712% | |
| 1.6015% | |
| -5.7995% | |
| 26.8887% | |
| -13.7% | |
| 14.2916% | |
| -4.423% | |
| 12.6888% | |
| -11.5843% | |
| -7.0319% | |
| 21.9905% | |
| 2.4072% | |
| -4.3412% | |
| 8.7307% | |
| -12.8018% | |
| 6.781% | |
| -4.8553% | |
| 15.0604% | |
| 3.5771% | |
| 8.0978% | |
| -42.3576% | |
| 6.9086% | |
| -1.4981% | |
| -0.3715% | |
| -14.1104% | |
| 4.5007% | |
| -5.3236% | |
| 12.3492% | |
| 1.8932% | |
| 13.6239% | |
| -4.8069% | |
| 10.8739% | |
| 1.3054% | |
| 5.8957% | |
| -8.6436% | |
| 27.2333% | |
| -3.0088% | |
| 6.6537% | |
| 19.3666% | |
| 15.364% | |
| 19.2375% | |
| 2.5119% | |
| -1.0845% | |
| 12.2677% | |
| -6.9415% | |
| 36.5784% | |
| 13.067% | |
| 29.695% | |
| 13.9276% | |
| 3.2156% | |
| 14.2383% | |
| 13.0518% | |
| 2.1114% | |
| 14.5642% | |
| -6.3557% | |
| 9.5487% | |
| 0% |